Por: MarketWatch Business September 21, 2023
Outside the GLP-1 revels, their echo casts gloom over shares of businesses that grew with America’s waistlines. Insulin-pump makers (PODD) and (TNDM) are down 40% and 50% this year, respectively, while the glucose monitor leader (DXCM) has lost 16%. (RMD) dominates the devices called “CPAP” machines that treat sleep apnea. Its stock is off 30%. (INSP) sells another sleep apnea device, and its shares have dropped 18%. Liver-disease drug... + full article
Time USA Health June 30, 2023
As popular as the latest drugs being touted for weight loss, including , , and , are on social media, like any medications, they don’t work in the same way for everyone. Not all are even approved to treat obesity, but are being used off label as a relatively easy way to shed... + más
Goldman Sachs just dropped the names of its biggest partner class since David Solomon took over as CEO. See the full list here. | Business Insider
2023 Women’s World Cup Schedule | Associated Press
ABC News USA Business January 10, 2023
Children struggling with obesity should be evaluated and treated early and aggressively, including with medications for kids as young as 12 and surgery for those as young as 13, according to new guidelines released Monday.The longstanding practice of “watchful waiting, or... + más
New guidance: Use drugs, surgery early for obesity in kids | ABC News
Use drugs and surgery early for obesity in kids, new guidance says | Orlando Sentinel
Orlando Sentinel USA Business January 09, 2023
Children struggling with obesity should be evaluated and treated early and aggressively, including with medications for kids as young as 12 and surgery for those as young as 13, according to new guidelines released Monday. The longstanding practice of “watchful waiting,” or... + más
ABC News USA Health January 09, 2023
Children struggling with obesity should be evaluated and treated early and aggressively, including with medications for kids as young as 12 and surgery for those as young as 13, according to new guidelines released Monday. The longstanding practice of “watchful waiting, or... + más
Portland Press Herald USA Health January 09, 2023
MarketWatch USA Business October 02, 2022
For the roughly 42% of Americans who are obese, these results are nothing short of a miracle. Wall Street is thrilled, predicting a global market for the drugs as big as by 2030. And physicians feel they finally have a new treatment option for their patients. “I was... + más
‘There's no way that patients are going to be able to afford that.’ Why aren’t new drugs that can help you lose weight more widely used? | MarketWatch
TikTok pulls posts for weight loss drugs that reached kids | The Verge
MarketWatch USA Politics October 02, 2022
About iurex | Privacy Policy | Disclaimer |